JNM Global

Global Approval Partner

전체 글 2559

Saudi Arabia SFDA, Announcement of Guidance on ISO 13485 Requirements and Corresponding SFDA-MDS Requirements

On March 25, 2025, a guidance document was issued to provide compliance instructions on ISO 13485:2016 Medical Devices-Quality Management System-Requirements (ISO 13485) for medical device manufacturers, authorized representatives, importers, and distributors, considering the regulatory documents issued by the Saudi Food and Drug Authority (SFDA) Medical Devices Sector (MDS).  Manufacturers, imp..

UK SCPN, Announcement of restrictions on the use of Methyl salicylate hydroxybenzoate in Cosmetics

On March 31, 2025, the United Kingdom issued the final draft of the Cosmetics (Chemical Restrictions) Regulation 2025 to impose restrictions on the use of Methyl salicylate hydroxybenzoate (CAS No. 119-36-8). This substance is classified as a Category CMR (2) substance under the EU Regulation (EC) No. 1272/2008 on classification, labeling, and packaging. As a result, the item for Methyl Salicyla..

JNM Global/Cosmetic 2025.04.04

Korea MFDS, Notice of Abolition of the Regulation on Natural and Organic Cosmetics

Following the amendment of the Cosmetics Act on January 31, 2025, which abolished government certification for natural and organic cosmetics, the Ministry of Food and Drug Safety (MFDS) announced a draft notice on March 26, 2025, regarding the repeal of the Regulation on Standards for Natural and Organic Cosmetics and the Regulation on the Designation and Certification of Certification Bodies fo..

JNM Global/Cosmetic 2025.03.28

Malaysia MDA, Announcement of the first edition of guidelines on the importation of medical devices for re-export(IRE)

To import, distribute, and supply medical devices in the Malaysia market, compliance with the requirements of the Medical Device Act 2012 (Act 737), including medical device registration, is required.  However, if medical devices need to be imported and re-exported for purposes such as maintenance, testing, sterilization, packaging, labeling, distribution hurbs, or other purposes designated by t..

Brazil ANVISA, Postponement of the implementation date for the cosmetics classification rules update

On February 26, 2025, Brazil’s ANVISA announced an amended resolution, Resolution RDC No. 966 (2025), which postpones the effective date of the updated product classification rules for cosmetics under Resolution RDC No. 949 (2024).For details on the updated cosmetic product classification, please refer to the previously posted link below.https://blog.naver.com/PostView.naver?blogId=jnm-ko-rea&lo..

JNM Global/Cosmetic 2025.03.21

France CPNP, Legislation passed on per- and polyfluoroalkyl substance (PFAS) in Cosmetics

On February 27, 2025, the French government enacted and promulgated legislation regulating per-and polyfluoroalkyl substances (PFAS) in certain products – such as cosmetics, wax-based products, and textile clothing – in order to prevent risks associated with PFAS exposure and to protect public health and the environment.  PFAS are chemical substances commonly used in various products such as foo..

JNM Global/Cosmetic 2025.03.21

Korea MFDS, Announcement of the introduction of a combined review system for KGMP and MDSAP

On March 11, 2025, the Ministry of Food and Drug Safety (MFDS) of Korea announced a public notice regarding the partial revision of the standards for medical device manufacturing and quality control. This revision aims to allow domestic export companies to undergo both KGMP and Medical Device Single Audit Program (MDSAP) simultaneously.  The revision provides a legal basis for combining the ‘MDS..

Korea MFDS, Establishment of the Enforcement Rule of the Digital Medical Products Act

On February 28, 2025, the Enforcement Rule of the Digital Medical Products Act was established to define the delegated matters and necessary implementation details following the enactment of the Digital Medical Products Act (effective January 24, 2025) and its Enforcement Decree (effective January 24, 2025).The key provisions of the Enforcement Rule include:1) Specific criteria for the classific..

UK MHRA, New Guidance on Digital Mental Health Technologies (DMHT)

On February 3, 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) announced new guidance on Digital Mental Health Technologies (DMHT) due to the increasing use of mental health apps, AI-based assessments, virtual reality therapies, and other digital mental health technologies. This new guidance is aimed at manufacturers.  The guidance document helps manufacturers identify th..